Low-dose Naltrexone (LDN) extends healthspan and lifespan through activation of the transcription factor SKN-1/NRF2 in C. elegans.
Preprint in Research Square (June 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Preprint in Research Square (June 2023)
Article in Environmental Health Perspectives (January 2023)
Article in Biomedicines (October 2022)